Drug Trial Radar · NCT02220920
Efficacy and Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus
Last checked: Nov 20, 2026Latest source record: Jan 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
146
Actual
Start
Aug 2014
Primary completion
Jul 2015
Study completion Jul 2015
Sponsor
- Lead sponsor
- Tanabe Pharma CorporationIndustry
- Sponsor type
- Industry
- First posted
- Aug 20, 2014
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of Canagliflozin (TA-7284) in combination with Insulin in patients with type 2 Diabetes for 16 weeks administration.
Conditions
- Type 2 Diabetes Mellitus
Interventions
Canagliflozin (TA-7284)Drug
The patients will receive Canagliflozin orally for 16 weeks
PlaceboDrug
The patients will receive Placebo orally for 16 weeks
InsulinDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in HbA1c From BaselineTime frame: baseline and Week 16
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Reserch site
Chūbu, Japan
Reserch site
Chugoku, Japan
Reserch site
Hokkaido, Japan
Reserch site
Kanto, Japan
Reserch site
Kinki, Japan
Reserch site
Kyushu, Japan
Reserch site
Tōhoku, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.